Siklosporin (Turkish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Siklosporin" in Turkish language version.

refsWebsite

Global rank Turkish rank

50nih.gov

4^th place

11^th place

41doi.org

2^nd place

4^th place

32web.archive.org

1^st place

5archive.org

6^th place

4handle.net

102^nd place

447^th place

3drugs.com

399^th place

156^th place

3harvard.edu

18^th place

47^th place

3fda.gov

447^th place

858^th place

2hres.ca

low place

2books.google.com

3^rd place

5^th place

2clincalc.com

3,912^th place

2,106^th place

1reference.com

657^th place

326^th place

1europa.eu

68^th place

79^th place

1khu.ac.kr

low place

1annals.edu.sg

low place

1asnjournals.org

low place

1iarc.fr

4,025^th place

7,496^th place

1ucl.ac.uk

1,306^th place

1,131^st place

1springer.de

low place

1smw.ch

low place

1latimes.com

22^nd place

138^th place

1columbiasurgery.org

low place

1archives-ouvertes.fr

1,031^st place

3,199^th place

1santen.com

low place

1clinicaltrials.gov

5,225^th place

low place

1neurovive.com

low place

1lu.se

4,012^th place

4,713^th place

annals.edu.sg

Lee SS, Tan AW, Giam YC (May 2004). "Cyclosporin in the treatment of severe atopic dermatitis: a retrospective study" (PDF). Annals of the Academy of Medicine, Singapore. 33 (3): 311-313. PMID 15175770. 21 Ocak 2022 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 11 Ekim 2021.

archive.org

World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (Ed.). WHO Model Formulary 2008. World Health Organization. s. 221. hdl:10665/44053. ISBN 9789241547659.
Ganong WF (2005). "27". Review of medical physiology (22.22isbn=978-0-07-144040-0 bas.). New York: McGraw-Hill Medical. s. 530.
Handschumacher RE, Harding MW, Rice J, Drugge RJ, Speicher DW (November 1984). "Cyclophilin: a specific cytosolic binding protein for cyclosporin A". Science. 226 (4674): 544-7. Bibcode:1984Sci...226..544H. doi:10.1126/science.6238408. PMID 6238408.
Copeland KR, Yatscoff RW, McKenna RM (February 1990). "Immunosuppressive activity of cyclosporine metabolites compared and characterized by mass spectroscopy and nuclear magnetic resonance". Clinical Chemistry. 36 (2): 225-9. doi:10.1093/clinchem/36.2.225. PMID 2137384.
Kolata G (September 1983). "FDA speeds approval of cyclosporin". Science. 221 (4617): 1273. Bibcode:1983Sci...221.1273K. doi:10.1126/science.221.4617.1273-a. PMID 17776314. On 2 September (1983), the Food and Drug Administration approved cyclosporin, a new drug that suppresses the immune system.

archives-ouvertes.fr

hal.archives-ouvertes.fr

Gibaud S, Attivi D (August 2012). "Microemulsions for oral administration and their therapeutic applications". Expert Opinion on Drug Delivery. 9 (8): 937-51. doi:10.1517/17425247.2012.694865. PMID 22663249. 5 Mart 2018 tarihinde kaynağından arşivlendi. Erişim tarihi: 4 Mart 2018.

asnjournals.org

cjasn.asnjournals.org

Naesens M, Kuypers DR, Sarwal M (February 2009). "Calcineurin inhibitor nephrotoxicity" (PDF). Clinical Journal of the American Society of Nephrology. 4 (2): 481-508. doi:10.2215/CJN.04800908. PMID 19218475. 20 Temmuz 2018 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 20 Nisan 2018.

books.google.com

Watts R, Clunie G, Hall F, Marshall T (2009). Rheumatology. Oxford University Press. s. 558. ISBN 978-0-19-922999-4. 5 Kasım 2017 tarihinde kaynağından arşivlendi.
Borel JF, Kis ZL, Beveridge T (1995). "The history of the discovery and development of Cyclosporin (Sandimmune)". Merluzzi VJ, Adams J (Ed.). The search for anti-inflammatory drugs case histories from concept to clinic. Boston: Birkhäuser. ss. 27-63. ISBN 978-1-4615-9846-6. 5 Kasım 2017 tarihinde kaynağından arşivlendi.

clincalc.com

"The Top 300 of 2020". ClinCalc. 12 Şubat 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 7 Ekim 2022.
"Cyclosporine - Drug Usage Statistics". ClinCalc. 8 Temmuz 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 7 Ekim 2022.

clinicaltrials.gov

National Heart, Lung, and Blood Institute (NHLBI) (4 Eylül 2020). "Phase II Trial of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for Treatment of Bronchiolitis Obliterans Syndrome". 25 Mart 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 Haziran 2023.

columbiasurgery.org

"First Successful Pediatric Heart Transplant [9 June 1984]". Columbia University Medical Center, Dept. of Surgery, Cardiac Transplant Program. 1 Mart 2017 tarihinde kaynağından arşivlendi. It [cyclosporine] gained FDA approval at the end of 1983, ...

doi.org

Matsuda S, Koyasu S (May 2000). "Mechanisms of action of cyclosporine" (PDF). Immunopharmacology. 47 (2–3): 119-25. doi:10.1016/S0162-3109(00)00192-2. PMID 10878286. 11 Ağustos 2017 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 4 Mart 2018.
Reinhard T (2000). "Lokales Cyclosporin A bei Nummuli nach Keratoconjunctivitis epidemica Eine Pilotstudie - Springer". Der Ophthalmologe. 97 (11): 764-768. doi:10.1007/s003470070025. PMID 11130165.
Dijkmans BA, van Rijthoven AW, Goei Thè HS, Boers M, Cats A (August 1992). "Cyclosporine in rheumatoid arthritis". Seminars in Arthritis and Rheumatism. 22 (1): 30-36. doi:10.1016/0049-0172(92)90046-g. PMID 1411580.
Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, Michelassi F, Hanauer S (June 1994). "Cyclosporine in severe ulcerative colitis refractory to steroid therapy". The New England Journal of Medicine. 330 (26): 1841-5. doi:10.1056/NEJM199406303302601. PMID 8196726.
Naesens M, Kuypers DR, Sarwal M (February 2009). "Calcineurin inhibitor nephrotoxicity" (PDF). Clinical Journal of the American Society of Nephrology. 4 (2): 481-508. doi:10.2215/CJN.04800908. PMID 19218475. 20 Temmuz 2018 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 20 Nisan 2018.
Robert N, Wong GW, Wright JM (January 2010). "Effect of cyclosporine on blood pressure". Cochrane Database of Systematic Reviews (1): CD007893. doi:10.1002/14651858.CD007893.pub2. PMID 20091657.
Figg WD (February 1990). "Cyclosporine-induced hyperuricemia and gout". The New England Journal of Medicine. 322 (5): 334-336. doi:10.1056/NEJM199002013220514. PMID 2296276.
Mott JL, Zhang D, Freeman JC, Mikolajczak P, Chang SW, Zassenhaus HP (July 2004). "Cardiac disease due to random mitochondrial DNA mutations is prevented by cyclosporin A". Biochemical and Biophysical Research Communications. 319 (4): 1210-5. doi:10.1016/j.bbrc.2004.05.104. PMID 15194495.
Youn TJ, Piao H, Kwon JS, Choi SY, Kim HS, Park DG, Kim DW, Kim YG, Cho MC (December 2002). "Effects of the calcineurin dependent signaling pathway inhibition by cyclosporin A on early and late cardiac remodeling following myocardial infarction". European Journal of Heart Failure. 4 (6): 713-8. doi:10.1016/S1388-9842(02)00120-4. PMID 12453541.
Handschumacher RE, Harding MW, Rice J, Drugge RJ, Speicher DW (November 1984). "Cyclophilin: a specific cytosolic binding protein for cyclosporin A". Science. 226 (4674): 544-7. Bibcode:1984Sci...226..544H. doi:10.1126/science.6238408. PMID 6238408.
Elrod JW, Wong R, Mishra S, Vagnozzi RJ, Sakthievel B, Goonasekera SA, Karch J, Gabel S, Farber J, Force T, Brown JH, Murphy E, Molkentin JD (October 2010). "Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and propensity for heart failure in mice". Journal of Clinical Investigation. 120 (10): 3680-7. doi:10.1172/JCI43171. PMC 2947235 $2. PMID 20890047.
Briston T, Selwood DL, Szabadkai G, Duchen MR (January 2019). "Mitochondrial Permeability Transition: A Molecular Lesion with Multiple Drug Targets" (PDF). Trends in Pharmacological Sciences. 40 (1): 50-70. doi:10.1016/j.tips.2018.11.004. PMID 30527591. 21 Ocak 2022 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 2 Ağustos 2021.
Morciano G, Giorgi C, Bonora M, Punzetti S, Pavasini R, Wieckowski MR, Campo G, Pinton P (January 2015). "Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury". Journal of Molecular and Cellular Cardiology. 78: 142-53. doi:10.1016/j.yjmcc.2014.08.015. hdl:11392/2149014. PMID 25172387.
Zorov DB, Juhaszova M, Sollott SJ (July 2014). "Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release". Physiological Reviews. 94 (3): 909-50. doi:10.1152/physrev.00026.2013. PMC 4101632 $2. PMID 24987008.
Copeland KR, Yatscoff RW, McKenna RM (February 1990). "Immunosuppressive activity of cyclosporine metabolites compared and characterized by mass spectroscopy and nuclear magnetic resonance". Clinical Chemistry. 36 (2): 225-9. doi:10.1093/clinchem/36.2.225. PMID 2137384.
Lawen A (October 2015). "Biosynthesis of cyclosporins and other natural peptidyl prolyl cis/trans isomerase inhibitors". Biochimica et Biophysica Acta (BBA) - General Subjects. 1850 (10): 2111-20. doi:10.1016/j.bbagen.2014.12.009. PMID 25497210.
Dittmann J, Wenger RM, Kleinkauf H, Lawen A (January 1994). "Mechanism of cyclosporin A biosynthesis. Evidence for synthesis via a single linear undecapeptide precursor". Journal of Biological Chemistry. 269 (4): 2841-6. doi:10.1016/S0021-9258(17)42019-9. PMID 8300618.
Hoppert M, Gentzsch C, Schörgendorfer K (October 2001). "Structure and localization of cyclosporin synthetase, the key enzyme of cyclosporin biosynthesis in Tolypocladium inflatum" (PDF). Archives of Microbiology. 176 (4): 285-93. doi:10.1007/s002030100324. PMID 11685373.
Yang X, Feng P, Yin Y, Bushley K, Spatafora JW, Wang C (October 2018). "Tolypocladium inflatum Benefits Fungal Adaptation to the Environment". mBio. 9 (5). doi:10.1128/mBio.01211-18. PMC 6168864 $2. PMID 30279281.
Bushley KE, Raja R, Jaiswal P, Cumbie JS, Nonogaki M, Boyd AE, Owensby CA, Knaus BJ, Elser J, Miller D, Di Y, McPhail KL, Spatafora JW (June 2013). "The genome of tolypocladium inflatum: evolution, organization, and expression of the cyclosporin biosynthetic gene cluster". PLOS Genetics. 9 (6): e1003496. doi:10.1371/journal.pgen.1003496. PMC 3688495 $2. PMID 23818858.
Xu L, Li Y, Biggins JB, Bowman BR, Verdine GL, Gloer JB, Alspaugh JA, Bills GF (March 2018). "Identification of cyclosporin C from Amphichorda felina using a Cryptococcus neoformans differential temperature sensitivity assay". Applied Microbiology and Biotechnology. 102 (5): 2337-2350. doi:10.1007/s00253-018-8792-0. PMC 5942556 $2. PMID 29396588.
di Salvo ML, Florio R, Paiardini A, Vivoli M, D'Aguanno S, Contestabile R (January 2013). "Alanine racemase from Tolypocladium inflatum: a key PLP-dependent enzyme in cyclosporin biosynthesis and a model of catalytic promiscuity". Archives of Biochemistry and Biophysics. 529 (2): 55-65. doi:10.1016/j.abb.2012.11.011. PMID 23219598.
Cheng M (2013). "Hartmann Stahelin (1925-2011) and the contested history of cyclosporin A". Clinical Transplantation. 27 (3): 326-329. doi:10.1111/ctr.12072. PMID 23331048.
Borel JF, Feurer C, Gubler HU, Stähelin H (July 1976). "Biological effects of cyclosporin A: a new antilymphocytic agent". Agents and Actions. 6 (4): 468-75. doi:10.1007/bf01973261. PMID 8969.
Rüegger A, Kuhn M, Lichti H, Loosli HR, Huguenin R, Quiquerez C, von Wartburg A (1976). "[Cyclosporin A, a Peptide Metabolite from Trichoderma polysporum (Link ex Pers.) Rifai, with a remarkable immunosuppressive activity]" [Cyclosporin A, a Peptide Metabolite from Trichoderma polysporum (Link ex Pers.) Rifai, with a remarkable immunosuppressive activity]. Helvetica Chimica Acta (Almanca). 59 (4): 1075-92. doi:10.1002/hlca.19760590412. PMID 950308.
Heusler K, Pletscher A (June 2001). "The controversial early history of cyclosporin". Swiss Medical Weekly. 131 (21–22): 299-302. doi:10.4414/smw.2001.09702. PMID 11584691. 2 Eylül 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Ocak 2019.
Calne RY, White DJ, Thiru S, Evans DB, McMaster P, Dunn DC, Craddock GN, Pentlow BD, Rolles K (1978). "Cyclosporin A in patients receiving renal allografts from cadaver donors". The Lancet. 2 (8104–5): 1323-7. doi:10.1016/S0140-6736(78)91970-0. PMID 82836.
Starzl TE, Klintmalm GB, Porter KA, Iwatsuki S, Schröter GP (July 1981). "Liver transplantation with use of cyclosporin a and prednisone". The New England Journal of Medicine. 305 (5): 266-9. doi:10.1056/NEJM198107303050507. PMC 2772056 $2. PMID 7017414.
Kolata G (September 1983). "FDA speeds approval of cyclosporin". Science. 221 (4617): 1273. Bibcode:1983Sci...221.1273K. doi:10.1126/science.221.4617.1273-a. PMID 17776314. On 2 September (1983), the Food and Drug Administration approved cyclosporin, a new drug that suppresses the immune system.
Gibaud S, Attivi D (August 2012). "Microemulsions for oral administration and their therapeutic applications". Expert Opinion on Drug Delivery. 9 (8): 937-51. doi:10.1517/17425247.2012.694865. PMID 22663249. 5 Mart 2018 tarihinde kaynağından arşivlendi. Erişim tarihi: 4 Mart 2018.
Min DI (March 1996). "Neoral: a microemulsion cyclosporine". Journal of Transplant Coordination. 6 (1): 5-8. doi:10.7182/prtr.1.6.1.f04016025hh795up. PMID 9157923.
Trammer B, Amann A, Haltner-Ukomadu E, Tillmanns S, Keller M, Högger P (November 2008). "Comparative permeability and diffusion kinetics of cyclosporine A liposomes and propylene glycol solution from human lung tissue into human blood ex vivo". European Journal of Pharmaceutics and Biopharmaceutics. 70 (3): 758-64. doi:10.1016/j.ejpb.2008.07.001. PMID 18656538.
Ehinger KH, Hansson MJ, Sjövall F, Elmér E (January 2013). "Bioequivalence and tolerability assessment of a novel intravenous ciclosporin lipid emulsion compared to branded ciclosporin in Cremophor EL" (PDF). Clinical Drug Investigation. 33 (1): 25-34. doi:10.1007/s40261-012-0029-x. PMC 3586182 $2. PMID 23179472. 26 Ekim 2018 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 26 Ekim 2018.
Sullivan PG, Thompson M, Scheff SW (February 2000). "Continuous infusion of cyclosporin A postinjury significantly ameliorates cortical damage following traumatic brain injury". Experimental Neurology. 161 (2): 631-7. doi:10.1006/exnr.1999.7282. PMID 10686082.
Uchino H, Elmér E, Uchino K, Lindvall O, Siesjö BK (December 1995). "Cyclosporin A dramatically ameliorates CA1 hippocampal damage following transient forebrain ischaemia in the rat". Acta Physiologica Scandinavica. 155 (4): 469-71. doi:10.1111/j.1748-1716.1995.tb09999.x. PMID 8719269.
Sullivan PG, Sebastian AH, Hall ED (February 2011). "Therapeutic window analysis of the neuroprotective effects of cyclosporine A after traumatic brain injury". Journal of Neurotrauma. 28 (2): 311-8. doi:10.1089/neu.2010.1646. PMC 3037811 $2. PMID 21142667.
Mende U, Kagen A, Cohen A, Aramburu J, Schoen FJ, Neer EJ (November 1998). "Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways". Proceedings of the National Academy of Sciences of the United States of America. 95 (23): 13893-8. Bibcode:1998PNAS...9513893M. doi:10.1073/pnas.95.23.13893. PMC 24952 $2. PMID 9811897.
Wilkinson ST, Johnson DB, Tardif HL, Tome ME, Briehl MM (March 2010). "Increased cytochrome c correlates with poor survival in aggressive lymphoma". Oncology Letters. 1 (2): 227-230. doi:10.3892/ol_00000040. PMC 2927837 $2. PMID 20798784.
Lim HW, De Windt LJ, Mante J, Kimball TR, Witt SA, Sussman MA, Molkentin JD (April 2000). "Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition". Journal of Molecular and Cellular Cardiology. 32 (4): 697-709. doi:10.1006/jmcc.2000.1113. PMID 10756124.
Archer TM, Boothe DM, Langston VC, Fellman CL, Lunsford KV, Mackin AJ (2014). "Oral cyclosporine treatment in dogs: a review of the literature". Journal of Veterinary Internal Medicine. 28 (1): 1-20. doi:10.1111/jvim.12265. PMC 4895546 $2. PMID 24341787.
Palmeiro BS (January 2013). "Cyclosporine in veterinary dermatology". Veterinary Clinics of North America: Small Animal Practice. 43 (1): 153-71. doi:10.1016/j.cvsm.2012.09.007. PMID 23182330.

drugs.com

"Cyclosporine". The American Society of Health-System Pharmacists. 17 Ekim 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 8 Aralık 2016.
"Cyclosporine eent". The American Society of Health-System Pharmacists. 13 Ocak 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 8 Aralık 2016.
"Cyclosporine Use During Pregnancy". Drugs.com. 14 Eylül 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 20 Aralık 2016.

europa.eu

ema.europa.eu

"Ikervis". European Medicines Agency. 17 Eylül 2018. 13 Ağustos 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 27 Şubat 2023.

fda.gov

accessdata.fda.gov

"Drugs@FDA: FDA Approved Drug Products [Click on "Approval Date(s) and History]". United States Food and Drug Administration. 1 Mart 2017 tarihinde kaynağından arşivlendi. Drug Name(s): Sandimmune (Cyclosporine), Company: Novartis, Action Date: 11/14/1983, Action Type: Approval, Submission Classification: Type 1 - New Molecular Entity, Review Priority: Priority
"Neoral" (PDF). FDA Data Dashboard. Food and Drug Administration (FDA); Novartis. September 2009. 20 Ekim 2022 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 24 Ekim 2022.

fda.gov

"FDA Approves First Generic of Restasis". U.S. Food and Drug Administration (FDA) (Basın açıklaması). 2 Şubat 2022. 2 Şubat 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Şubat 2022.

handle.net

hdl.handle.net

World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (Ed.). WHO Model Formulary 2008. World Health Organization. s. 221. hdl:10665/44053. ISBN 9789241547659.
World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Cenevre: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Cenevre: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.
Morciano G, Giorgi C, Bonora M, Punzetti S, Pavasini R, Wieckowski MR, Campo G, Pinton P (January 2015). "Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury". Journal of Molecular and Cellular Cardiology. 78: 142-53. doi:10.1016/j.yjmcc.2014.08.015. hdl:11392/2149014. PMID 25172387.

harvard.edu

adsabs.harvard.edu

Handschumacher RE, Harding MW, Rice J, Drugge RJ, Speicher DW (November 1984). "Cyclophilin: a specific cytosolic binding protein for cyclosporin A". Science. 226 (4674): 544-7. Bibcode:1984Sci...226..544H. doi:10.1126/science.6238408. PMID 6238408.
Kolata G (September 1983). "FDA speeds approval of cyclosporin". Science. 221 (4617): 1273. Bibcode:1983Sci...221.1273K. doi:10.1126/science.221.4617.1273-a. PMID 17776314. On 2 September (1983), the Food and Drug Administration approved cyclosporin, a new drug that suppresses the immune system.
Mende U, Kagen A, Cohen A, Aramburu J, Schoen FJ, Neer EJ (November 1998). "Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways". Proceedings of the National Academy of Sciences of the United States of America. 95 (23): 13893-8. Bibcode:1998PNAS...9513893M. doi:10.1073/pnas.95.23.13893. PMC 24952 $2. PMID 9811897.

hres.ca

hpr-rps.hres.ca

"Search Page - Drug and Health Product Register". 23 Ekim 2014. 7 Haziran 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 7 Haziran 2022.
"Search Page - Drug and Health Product Register". 23 Ekim 2014. 7 Haziran 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 7 Haziran 2022.

iarc.fr

monographs.iarc.fr

Agents Classified by the IARC Monographs, Volumes 1–110 25 Ekim 2011 tarihinde Wayback Machine sitesinde arşivlendi.

khu.ac.kr

web.khu.ac.kr

Matsuda S, Koyasu S (May 2000). "Mechanisms of action of cyclosporine" (PDF). Immunopharmacology. 47 (2–3): 119-25. doi:10.1016/S0162-3109(00)00192-2. PMID 10878286. 11 Ağustos 2017 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 4 Mart 2018.

latimes.com

articles.latimes.com

Gottesman J (20 Mart 1988). "Milestones in Cardiac Care". Los Angeles Times. 26 Şubat 2017 tarihinde kaynağından arşivlendi.

lu.se

lup.lub.lu.se

Ehinger KH, Hansson MJ, Sjövall F, Elmér E (January 2013). "Bioequivalence and tolerability assessment of a novel intravenous ciclosporin lipid emulsion compared to branded ciclosporin in Cremophor EL" (PDF). Clinical Drug Investigation. 33 (1): 25-34. doi:10.1007/s40261-012-0029-x. PMC 3586182 $2. PMID 23179472. 26 Ekim 2018 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 26 Ekim 2018.

neurovive.com

Administrator. "Hem - NeuroVive Pharmaceutical AB". neurovive.com. 6 Ocak 2014 tarihinde kaynağından arşivlendi.

nih.gov

ncbi.nlm.nih.gov

Laupacis A, Keown PA, Ulan RA, McKenzie N, Stiller CR (May 1982). "Cyclosporin A: a powerful immunosuppressant". Canadian Medical Association Journal. 126 (9): 1041-6. PMC 1863293 $2. PMID 7074504.
Matsuda S, Koyasu S (May 2000). "Mechanisms of action of cyclosporine" (PDF). Immunopharmacology. 47 (2–3): 119-25. doi:10.1016/S0162-3109(00)00192-2. PMID 10878286. 11 Ağustos 2017 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 4 Mart 2018.
Reinhard T (2000). "Lokales Cyclosporin A bei Nummuli nach Keratoconjunctivitis epidemica Eine Pilotstudie - Springer". Der Ophthalmologe. 97 (11): 764-768. doi:10.1007/s003470070025. PMID 11130165.
Lee SS, Tan AW, Giam YC (May 2004). "Cyclosporin in the treatment of severe atopic dermatitis: a retrospective study" (PDF). Annals of the Academy of Medicine, Singapore. 33 (3): 311-313. PMID 15175770. 21 Ocak 2022 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 11 Ekim 2021.
Dijkmans BA, van Rijthoven AW, Goei Thè HS, Boers M, Cats A (August 1992). "Cyclosporine in rheumatoid arthritis". Seminars in Arthritis and Rheumatism. 22 (1): 30-36. doi:10.1016/0049-0172(92)90046-g. PMID 1411580.
Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, Michelassi F, Hanauer S (June 1994). "Cyclosporine in severe ulcerative colitis refractory to steroid therapy". The New England Journal of Medicine. 330 (26): 1841-5. doi:10.1056/NEJM199406303302601. PMID 8196726.
Naesens M, Kuypers DR, Sarwal M (February 2009). "Calcineurin inhibitor nephrotoxicity" (PDF). Clinical Journal of the American Society of Nephrology. 4 (2): 481-508. doi:10.2215/CJN.04800908. PMID 19218475. 20 Temmuz 2018 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 20 Nisan 2018.
Robert N, Wong GW, Wright JM (January 2010). "Effect of cyclosporine on blood pressure". Cochrane Database of Systematic Reviews (1): CD007893. doi:10.1002/14651858.CD007893.pub2. PMID 20091657.
Figg WD (February 1990). "Cyclosporine-induced hyperuricemia and gout". The New England Journal of Medicine. 322 (5): 334-336. doi:10.1056/NEJM199002013220514. PMID 2296276.
IARC Working Group on the Evaluation of Carcinogenic Risk to Humans (2012). Ciclosporin (İngilizce). International Agency for Research on Cancer. 28 Ağustos 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 23 Şubat 2018.
Mott JL, Zhang D, Freeman JC, Mikolajczak P, Chang SW, Zassenhaus HP (July 2004). "Cardiac disease due to random mitochondrial DNA mutations is prevented by cyclosporin A". Biochemical and Biophysical Research Communications. 319 (4): 1210-5. doi:10.1016/j.bbrc.2004.05.104. PMID 15194495.
Youn TJ, Piao H, Kwon JS, Choi SY, Kim HS, Park DG, Kim DW, Kim YG, Cho MC (December 2002). "Effects of the calcineurin dependent signaling pathway inhibition by cyclosporin A on early and late cardiac remodeling following myocardial infarction". European Journal of Heart Failure. 4 (6): 713-8. doi:10.1016/S1388-9842(02)00120-4. PMID 12453541.
Handschumacher RE, Harding MW, Rice J, Drugge RJ, Speicher DW (November 1984). "Cyclophilin: a specific cytosolic binding protein for cyclosporin A". Science. 226 (4674): 544-7. Bibcode:1984Sci...226..544H. doi:10.1126/science.6238408. PMID 6238408.
Elrod JW, Wong R, Mishra S, Vagnozzi RJ, Sakthievel B, Goonasekera SA, Karch J, Gabel S, Farber J, Force T, Brown JH, Murphy E, Molkentin JD (October 2010). "Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and propensity for heart failure in mice". Journal of Clinical Investigation. 120 (10): 3680-7. doi:10.1172/JCI43171. PMC 2947235 $2. PMID 20890047.
Briston T, Selwood DL, Szabadkai G, Duchen MR (January 2019). "Mitochondrial Permeability Transition: A Molecular Lesion with Multiple Drug Targets" (PDF). Trends in Pharmacological Sciences. 40 (1): 50-70. doi:10.1016/j.tips.2018.11.004. PMID 30527591. 21 Ocak 2022 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 2 Ağustos 2021.
Morciano G, Giorgi C, Bonora M, Punzetti S, Pavasini R, Wieckowski MR, Campo G, Pinton P (January 2015). "Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury". Journal of Molecular and Cellular Cardiology. 78: 142-53. doi:10.1016/j.yjmcc.2014.08.015. hdl:11392/2149014. PMID 25172387.
Zorov DB, Juhaszova M, Sollott SJ (July 2014). "Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release". Physiological Reviews. 94 (3): 909-50. doi:10.1152/physrev.00026.2013. PMC 4101632 $2. PMID 24987008.
Borel JF (June 2002). "History of the discovery of cyclosporin and of its early pharmacological development". Wiener Klinische Wochenschrift. 114 (12): 433-7. PMID 12422576.
Wang CP, Hartman NR, Venkataramanan R, Jardine I, Lin FT, Knapp JE, Starzl TE, Burckart GJ (1989). "Isolation of 10 cyclosporine metabolites from human bile". Drug Metabolism and Disposition. 17 (3): 292-6. PMC 3154783 $2. PMID 2568911.
Copeland KR, Yatscoff RW, McKenna RM (February 1990). "Immunosuppressive activity of cyclosporine metabolites compared and characterized by mass spectroscopy and nuclear magnetic resonance". Clinical Chemistry. 36 (2): 225-9. doi:10.1093/clinchem/36.2.225. PMID 2137384.
Lawen A (October 2015). "Biosynthesis of cyclosporins and other natural peptidyl prolyl cis/trans isomerase inhibitors". Biochimica et Biophysica Acta (BBA) - General Subjects. 1850 (10): 2111-20. doi:10.1016/j.bbagen.2014.12.009. PMID 25497210.
Dittmann J, Wenger RM, Kleinkauf H, Lawen A (January 1994). "Mechanism of cyclosporin A biosynthesis. Evidence for synthesis via a single linear undecapeptide precursor". Journal of Biological Chemistry. 269 (4): 2841-6. doi:10.1016/S0021-9258(17)42019-9. PMID 8300618.
Hoppert M, Gentzsch C, Schörgendorfer K (October 2001). "Structure and localization of cyclosporin synthetase, the key enzyme of cyclosporin biosynthesis in Tolypocladium inflatum" (PDF). Archives of Microbiology. 176 (4): 285-93. doi:10.1007/s002030100324. PMID 11685373.
Yang X, Feng P, Yin Y, Bushley K, Spatafora JW, Wang C (October 2018). "Tolypocladium inflatum Benefits Fungal Adaptation to the Environment". mBio. 9 (5). doi:10.1128/mBio.01211-18. PMC 6168864 $2. PMID 30279281.
Bushley KE, Raja R, Jaiswal P, Cumbie JS, Nonogaki M, Boyd AE, Owensby CA, Knaus BJ, Elser J, Miller D, Di Y, McPhail KL, Spatafora JW (June 2013). "The genome of tolypocladium inflatum: evolution, organization, and expression of the cyclosporin biosynthetic gene cluster". PLOS Genetics. 9 (6): e1003496. doi:10.1371/journal.pgen.1003496. PMC 3688495 $2. PMID 23818858.
Xu L, Li Y, Biggins JB, Bowman BR, Verdine GL, Gloer JB, Alspaugh JA, Bills GF (March 2018). "Identification of cyclosporin C from Amphichorda felina using a Cryptococcus neoformans differential temperature sensitivity assay". Applied Microbiology and Biotechnology. 102 (5): 2337-2350. doi:10.1007/s00253-018-8792-0. PMC 5942556 $2. PMID 29396588.
di Salvo ML, Florio R, Paiardini A, Vivoli M, D'Aguanno S, Contestabile R (January 2013). "Alanine racemase from Tolypocladium inflatum: a key PLP-dependent enzyme in cyclosporin biosynthesis and a model of catalytic promiscuity". Archives of Biochemistry and Biophysics. 529 (2): 55-65. doi:10.1016/j.abb.2012.11.011. PMID 23219598.
Cheng M (2013). "Hartmann Stahelin (1925-2011) and the contested history of cyclosporin A". Clinical Transplantation. 27 (3): 326-329. doi:10.1111/ctr.12072. PMID 23331048.
Borel JF, Feurer C, Gubler HU, Stähelin H (July 1976). "Biological effects of cyclosporin A: a new antilymphocytic agent". Agents and Actions. 6 (4): 468-75. doi:10.1007/bf01973261. PMID 8969.
Rüegger A, Kuhn M, Lichti H, Loosli HR, Huguenin R, Quiquerez C, von Wartburg A (1976). "[Cyclosporin A, a Peptide Metabolite from Trichoderma polysporum (Link ex Pers.) Rifai, with a remarkable immunosuppressive activity]" [Cyclosporin A, a Peptide Metabolite from Trichoderma polysporum (Link ex Pers.) Rifai, with a remarkable immunosuppressive activity]. Helvetica Chimica Acta (Almanca). 59 (4): 1075-92. doi:10.1002/hlca.19760590412. PMID 950308.
Heusler K, Pletscher A (June 2001). "The controversial early history of cyclosporin". Swiss Medical Weekly. 131 (21–22): 299-302. doi:10.4414/smw.2001.09702. PMID 11584691. 2 Eylül 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Ocak 2019.
Calne RY, White DJ, Thiru S, Evans DB, McMaster P, Dunn DC, Craddock GN, Pentlow BD, Rolles K (1978). "Cyclosporin A in patients receiving renal allografts from cadaver donors". The Lancet. 2 (8104–5): 1323-7. doi:10.1016/S0140-6736(78)91970-0. PMID 82836.
Starzl TE, Klintmalm GB, Porter KA, Iwatsuki S, Schröter GP (July 1981). "Liver transplantation with use of cyclosporin a and prednisone". The New England Journal of Medicine. 305 (5): 266-9. doi:10.1056/NEJM198107303050507. PMC 2772056 $2. PMID 7017414.
Kolata G (September 1983). "FDA speeds approval of cyclosporin". Science. 221 (4617): 1273. Bibcode:1983Sci...221.1273K. doi:10.1126/science.221.4617.1273-a. PMID 17776314. On 2 September (1983), the Food and Drug Administration approved cyclosporin, a new drug that suppresses the immune system.
Gibaud S, Attivi D (August 2012). "Microemulsions for oral administration and their therapeutic applications". Expert Opinion on Drug Delivery. 9 (8): 937-51. doi:10.1517/17425247.2012.694865. PMID 22663249. 5 Mart 2018 tarihinde kaynağından arşivlendi. Erişim tarihi: 4 Mart 2018.
Min DI (March 1996). "Neoral: a microemulsion cyclosporine". Journal of Transplant Coordination. 6 (1): 5-8. doi:10.7182/prtr.1.6.1.f04016025hh795up. PMID 9157923.
Trammer B, Amann A, Haltner-Ukomadu E, Tillmanns S, Keller M, Högger P (November 2008). "Comparative permeability and diffusion kinetics of cyclosporine A liposomes and propylene glycol solution from human lung tissue into human blood ex vivo". European Journal of Pharmaceutics and Biopharmaceutics. 70 (3): 758-64. doi:10.1016/j.ejpb.2008.07.001. PMID 18656538.
Ehinger KH, Hansson MJ, Sjövall F, Elmér E (January 2013). "Bioequivalence and tolerability assessment of a novel intravenous ciclosporin lipid emulsion compared to branded ciclosporin in Cremophor EL" (PDF). Clinical Drug Investigation. 33 (1): 25-34. doi:10.1007/s40261-012-0029-x. PMC 3586182 $2. PMID 23179472. 26 Ekim 2018 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 26 Ekim 2018.
Sullivan PG, Thompson M, Scheff SW (February 2000). "Continuous infusion of cyclosporin A postinjury significantly ameliorates cortical damage following traumatic brain injury". Experimental Neurology. 161 (2): 631-7. doi:10.1006/exnr.1999.7282. PMID 10686082.
Uchino H, Elmér E, Uchino K, Lindvall O, Siesjö BK (December 1995). "Cyclosporin A dramatically ameliorates CA1 hippocampal damage following transient forebrain ischaemia in the rat". Acta Physiologica Scandinavica. 155 (4): 469-71. doi:10.1111/j.1748-1716.1995.tb09999.x. PMID 8719269.
Sullivan PG, Sebastian AH, Hall ED (February 2011). "Therapeutic window analysis of the neuroprotective effects of cyclosporine A after traumatic brain injury". Journal of Neurotrauma. 28 (2): 311-8. doi:10.1089/neu.2010.1646. PMC 3037811 $2. PMID 21142667.
Mende U, Kagen A, Cohen A, Aramburu J, Schoen FJ, Neer EJ (November 1998). "Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways". Proceedings of the National Academy of Sciences of the United States of America. 95 (23): 13893-8. Bibcode:1998PNAS...9513893M. doi:10.1073/pnas.95.23.13893. PMC 24952 $2. PMID 9811897.
Wilkinson ST, Johnson DB, Tardif HL, Tome ME, Briehl MM (March 2010). "Increased cytochrome c correlates with poor survival in aggressive lymphoma". Oncology Letters. 1 (2): 227-230. doi:10.3892/ol_00000040. PMC 2927837 $2. PMID 20798784.
Lim HW, De Windt LJ, Mante J, Kimball TR, Witt SA, Sussman MA, Molkentin JD (April 2000). "Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition". Journal of Molecular and Cellular Cardiology. 32 (4): 697-709. doi:10.1006/jmcc.2000.1113. PMID 10756124.
Archer TM, Boothe DM, Langston VC, Fellman CL, Lunsford KV, Mackin AJ (2014). "Oral cyclosporine treatment in dogs: a review of the literature". Journal of Veterinary Internal Medicine. 28 (1): 1-20. doi:10.1111/jvim.12265. PMC 4895546 $2. PMID 24341787.
Palmeiro BS (January 2013). "Cyclosporine in veterinary dermatology". Veterinary Clinics of North America: Small Animal Practice. 43 (1): 153-71. doi:10.1016/j.cvsm.2012.09.007. PMID 23182330.

dailymed.nlm.nih.gov

"Neoral- cyclosporine capsule, liquid filled Neoral- cyclosporine solution". DailyMed. 5 Temmuz 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Şubat 2022.
"Sandimmune- cyclosporine capsule, liquid filled Sandimmune- cyclosporine injection Sandimmune- cyclosporine solution". DailyMed. 21 Nisan 2014 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Şubat 2022.
"Restasis- cyclosporine emulsion". DailyMed. 30 Mart 2014 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Şubat 2022.
"Vevye- cyclosporine ophthalmic solution solution/ drops". DailyMed. 26 Mayıs 2023. 29 Ağustos 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 29 Ağustos 2023.

reference.com

dictionary.reference.com

"cyclosporin". Dictionary.com Unabridged. Random House. n.d. 18 Kasım 2010 tarihinde kaynağından arşivlendi. Erişim tarihi: 13 Temmuz 2011.

santen.com

"Ikervis". Santen. 3 Temmuz 2018 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Temmuz 2018.

smw.ch

Heusler K, Pletscher A (June 2001). "The controversial early history of cyclosporin". Swiss Medical Weekly. 131 (21–22): 299-302. doi:10.4414/smw.2001.09702. PMID 11584691. 2 Eylül 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Ocak 2019.

springer.de

link.springer.de

Hoppert M, Gentzsch C, Schörgendorfer K (October 2001). "Structure and localization of cyclosporin synthetase, the key enzyme of cyclosporin biosynthesis in Tolypocladium inflatum" (PDF). Archives of Microbiology. 176 (4): 285-93. doi:10.1007/s002030100324. PMID 11685373.

ucl.ac.uk

discovery.ucl.ac.uk

Briston T, Selwood DL, Szabadkai G, Duchen MR (January 2019). "Mitochondrial Permeability Transition: A Molecular Lesion with Multiple Drug Targets" (PDF). Trends in Pharmacological Sciences. 40 (1): 50-70. doi:10.1016/j.tips.2018.11.004. PMID 30527591. 21 Ocak 2022 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 2 Ağustos 2021.

web.archive.org

"cyclosporin". Dictionary.com Unabridged. Random House. n.d. 18 Kasım 2010 tarihinde kaynağından arşivlendi. Erişim tarihi: 13 Temmuz 2011.
"Search Page - Drug and Health Product Register". 23 Ekim 2014. 7 Haziran 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 7 Haziran 2022.
"Search Page - Drug and Health Product Register". 23 Ekim 2014. 7 Haziran 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 7 Haziran 2022.
"Neoral- cyclosporine capsule, liquid filled Neoral- cyclosporine solution". DailyMed. 5 Temmuz 2013 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Şubat 2022.
"Sandimmune- cyclosporine capsule, liquid filled Sandimmune- cyclosporine injection Sandimmune- cyclosporine solution". DailyMed. 21 Nisan 2014 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Şubat 2022.
"Restasis- cyclosporine emulsion". DailyMed. 30 Mart 2014 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Şubat 2022.
"Vevye- cyclosporine ophthalmic solution solution/ drops". DailyMed. 26 Mayıs 2023. 29 Ağustos 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 29 Ağustos 2023.
"Ikervis". European Medicines Agency. 17 Eylül 2018. 13 Ağustos 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 27 Şubat 2023.
"Cyclosporine". The American Society of Health-System Pharmacists. 17 Ekim 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 8 Aralık 2016.
"Cyclosporine eent". The American Society of Health-System Pharmacists. 13 Ocak 2016 tarihinde kaynağından arşivlendi. Erişim tarihi: 8 Aralık 2016.
"Cyclosporine Use During Pregnancy". Drugs.com. 14 Eylül 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 20 Aralık 2016.
Matsuda S, Koyasu S (May 2000). "Mechanisms of action of cyclosporine" (PDF). Immunopharmacology. 47 (2–3): 119-25. doi:10.1016/S0162-3109(00)00192-2. PMID 10878286. 11 Ağustos 2017 tarihinde kaynağından (PDF) arşivlendi. Erişim tarihi: 4 Mart 2018.
Watts R, Clunie G, Hall F, Marshall T (2009). Rheumatology. Oxford University Press. s. 558. ISBN 978-0-19-922999-4. 5 Kasım 2017 tarihinde kaynağından arşivlendi.
"The Top 300 of 2020". ClinCalc. 12 Şubat 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 7 Ekim 2022.
"Cyclosporine - Drug Usage Statistics". ClinCalc. 8 Temmuz 2020 tarihinde kaynağından arşivlendi. Erişim tarihi: 7 Ekim 2022.
"FDA Approves First Generic of Restasis". U.S. Food and Drug Administration (FDA) (Basın açıklaması). 2 Şubat 2022. 2 Şubat 2022 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Şubat 2022.
Lee SS, Tan AW, Giam YC (May 2004). "Cyclosporin in the treatment of severe atopic dermatitis: a retrospective study" (PDF). Annals of the Academy of Medicine, Singapore. 33 (3): 311-313. PMID 15175770. 21 Ocak 2022 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 11 Ekim 2021.
Naesens M, Kuypers DR, Sarwal M (February 2009). "Calcineurin inhibitor nephrotoxicity" (PDF). Clinical Journal of the American Society of Nephrology. 4 (2): 481-508. doi:10.2215/CJN.04800908. PMID 19218475. 20 Temmuz 2018 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 20 Nisan 2018.
Agents Classified by the IARC Monographs, Volumes 1–110 25 Ekim 2011 tarihinde Wayback Machine sitesinde arşivlendi.
IARC Working Group on the Evaluation of Carcinogenic Risk to Humans (2012). Ciclosporin (İngilizce). International Agency for Research on Cancer. 28 Ağustos 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 23 Şubat 2018.
Briston T, Selwood DL, Szabadkai G, Duchen MR (January 2019). "Mitochondrial Permeability Transition: A Molecular Lesion with Multiple Drug Targets" (PDF). Trends in Pharmacological Sciences. 40 (1): 50-70. doi:10.1016/j.tips.2018.11.004. PMID 30527591. 21 Ocak 2022 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 2 Ağustos 2021.
Borel JF, Kis ZL, Beveridge T (1995). "The history of the discovery and development of Cyclosporin (Sandimmune)". Merluzzi VJ, Adams J (Ed.). The search for anti-inflammatory drugs case histories from concept to clinic. Boston: Birkhäuser. ss. 27-63. ISBN 978-1-4615-9846-6. 5 Kasım 2017 tarihinde kaynağından arşivlendi.
Heusler K, Pletscher A (June 2001). "The controversial early history of cyclosporin". Swiss Medical Weekly. 131 (21–22): 299-302. doi:10.4414/smw.2001.09702. PMID 11584691. 2 Eylül 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 10 Ocak 2019.
Gottesman J (20 Mart 1988). "Milestones in Cardiac Care". Los Angeles Times. 26 Şubat 2017 tarihinde kaynağından arşivlendi.
"First Successful Pediatric Heart Transplant [9 June 1984]". Columbia University Medical Center, Dept. of Surgery, Cardiac Transplant Program. 1 Mart 2017 tarihinde kaynağından arşivlendi. It [cyclosporine] gained FDA approval at the end of 1983, ...
"Drugs@FDA: FDA Approved Drug Products [Click on "Approval Date(s) and History]". United States Food and Drug Administration. 1 Mart 2017 tarihinde kaynağından arşivlendi. Drug Name(s): Sandimmune (Cyclosporine), Company: Novartis, Action Date: 11/14/1983, Action Type: Approval, Submission Classification: Type 1 - New Molecular Entity, Review Priority: Priority
Gibaud S, Attivi D (August 2012). "Microemulsions for oral administration and their therapeutic applications". Expert Opinion on Drug Delivery. 9 (8): 937-51. doi:10.1517/17425247.2012.694865. PMID 22663249. 5 Mart 2018 tarihinde kaynağından arşivlendi. Erişim tarihi: 4 Mart 2018.
"Neoral" (PDF). FDA Data Dashboard. Food and Drug Administration (FDA); Novartis. September 2009. 20 Ekim 2022 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 24 Ekim 2022.
"Ikervis". Santen. 3 Temmuz 2018 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Temmuz 2018.
National Heart, Lung, and Blood Institute (NHLBI) (4 Eylül 2020). "Phase II Trial of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for Treatment of Bronchiolitis Obliterans Syndrome". 25 Mart 2023 tarihinde kaynağından arşivlendi. Erişim tarihi: 11 Haziran 2023.
Administrator. "Hem - NeuroVive Pharmaceutical AB". neurovive.com. 6 Ocak 2014 tarihinde kaynağından arşivlendi.
Ehinger KH, Hansson MJ, Sjövall F, Elmér E (January 2013). "Bioequivalence and tolerability assessment of a novel intravenous ciclosporin lipid emulsion compared to branded ciclosporin in Cremophor EL" (PDF). Clinical Drug Investigation. 33 (1): 25-34. doi:10.1007/s40261-012-0029-x. PMC 3586182 $2. PMID 23179472. 26 Ekim 2018 tarihinde kaynağından arşivlendi (PDF). Erişim tarihi: 26 Ekim 2018.